Rights and permissions
About this article
Cite this article
Patients prefer IV to SC immunoglobulins. Inpharma Wkly. 983, 21 (1995). https://doi.org/10.2165/00128413-199509830-00045
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199509830-00045